Fabricnano

Market position

FabricNano frames itself against cell-based synthetic biology approaches, arguing cell-free, immobilized-enzyme processes are more efficient and scalable than engineered organisms. A third-party profile places it in the climate tech and synthetic biology segment addressing the fossil-fuel dependence of the chemical industry, and cites a target industrial market in excess of $75 billion; the same source's other figures are internally inconsistent [0][2][4].

Stated differentiators are a statistical, dataset-driven approach to immobilization rather than case-by-case protocol development; proprietary immobilization datasets used to guide surface mutagenesis (Interaction Engineering™) with a sub-two-month turnaround; productized screening via PIPs; and the use of carriers that are already purchasable on the open market at multi-tonne scale, which the company presents as removing a scale-up barrier. A third-party profile also cites drop-in compatibility with existing industrial reactors such as packed bed and stirred tank reactors [0][2][4].

Technology

The core technology is enzyme immobilization on solid supports for cell-free biocatalysis. FabricNano screens candidate support materials at high throughput to identify lead carriers, then engineers the immobilization protocol. Predictive Immobilization Plates (PIPs) package this screening into a 96-well plate format said to yield millions of datapoints. Interaction Engineering™ layers protein engineering on top: directed mutagenesis of enzyme surface residues, guided by proprietary immobilization datasets, to improve how enzymes bind and perform on carriers. The company describes its approach as a first-of-its-kind statistical method to immobilization, in contrast to earlier practice that traded enzyme activity for stability [0][2]. A secondary profile additionally attributes DNA-wafer-based enzyme immobilization and natural carriers such as rocks and coffee grinds to the company [4].

Go-to-market

Direct enquiry-based sales from the company website, with two entry points: purchase of a Predictive Immobilization Plate as a low-commitment product, and enquiry for Interaction Engineering™ service engagements. The site publishes case studies and a biocatalyst portfolio to support these offers, and lists enquiries@fabricnano.com as the commercial contact [0][2].

Companies with biocatalysis or enzyme-based production programs that need immobilized, scalable biocatalysts — described by a third-party profile as spanning chemicals, plastics, personal care, detergents, biofuels and pharmaceuticals, and including large chemical manufacturers [2][4].

Geography

Headquarters and laboratory in central London, UK, at 4th Floor, 184-192 Drummond Street, NW1 3HP, described as an expansive HQ with analytical equipment, microbiology kits and reactor rigs on the building's top floor [0][2][3]. A third-party profile also lists the company as London, England, United Kingdom based [4].

History

Public sourcing on the company's history is thin and partly contradictory. A third-party aggregator reports two funding rounds — a seed round announced July 2019 and a Series A announced June 2021 — while elsewhere on the same page citing a $12.5 million Series A and total raised figures of $16 million and "just under $25 million," and both 2018 founding and 201-500 versus 11-30 headcount ranges [4]. The same source states the company grew from 12 to 30 employees following its 2021 raise and launched FabricFlow reactors, and references a relationship with Sumitomo Chemical [4]. The company's own site currently presents a productized offering (PIPs) and an enzyme engineering service (Interaction Engineering™) [2].

Risks & controversies

The main issue evident in the material is data reliability rather than any reported controversy: the principal third-party profile [4] contains mutually inconsistent claims about founding year (2018), headcount (201-500 versus an estimated 11-30), and total funding ($16.0M versus "just under $25 million"), and attributes an unusually long and heterogeneous investor list to a single Series A, so its figures are low-confidence. Two retrieved documents [6][7] concern unrelated entities (a general article on post-acquisition shutdowns and Amazon's Fabric.com) and were disregarded as name twins.